Literature DB >> 35110611

Differentiation of intestinal tuberculosis and Crohn's disease through an explainable machine learning method.

Futian Weng1,2,3, Yu Meng4,5, Fanggen Lu6, Yuying Wang3,7, Weiwei Wang1,2,3, Long Xu4,5, Dongsheng Cheng8, Jianping Zhu9,10,11.   

Abstract

Differentiation between Crohn's disease and intestinal tuberculosis is difficult but crucial for medical decisions. This study aims to develop an effective framework to distinguish these two diseases through an explainable machine learning (ML) model. After feature selection, a total of nine variables are extracted, including intestinal surgery, abdominal, bloody stool, PPD, knot, ESAT-6, CFP-10, intestinal dilatation and comb sign. Besides, we compared the predictive performance of the ML methods with traditional statistical methods. This work also provides insights into the ML model's outcome through the SHAP method for the first time. A cohort consisting of 200 patients' data (CD = 160, ITB = 40) is used in training and validating models. Results illustrate that the XGBoost algorithm outperforms other classifiers in terms of area under the receiver operating characteristic curve (AUC), sensitivity, specificity, precision and Matthews correlation coefficient (MCC), yielding values of 0.891, 0.813, 0.969, 0.867 and 0.801 respectively. More importantly, the prediction outcomes of XGBoost can be effectively explained through the SHAP method. The proposed framework proves that the effectiveness of distinguishing CD from ITB through interpretable machine learning, which can obtain a global explanation but also an explanation for individual patients.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35110611      PMCID: PMC8810833          DOI: 10.1038/s41598-022-05571-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  22 in total

1.  From Local Explanations to Global Understanding with Explainable AI for Trees.

Authors:  Scott M Lundberg; Gabriel Erion; Hugh Chen; Alex DeGrave; Jordan M Prutkin; Bala Nair; Ronit Katz; Jonathan Himmelfarb; Nisha Bansal; Su-In Lee
Journal:  Nat Mach Intell       Date:  2020-01-17

Review 2.  Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1).

Authors:  Choon Jin Ooi; Govind K Makharia; Ida Hilmi; Peter R Gibson; Kwong Ming Fock; Vineet Ahuja; Khoon Lin Ling; Wee Chian Lim; Kelvin T Thia; Shu-chen Wei; Wai Keung Leung; Poh Koon Koh; Richard B Gearry; Khean Lee Goh; Qin Ouyang; Jose Sollano; Sathaporn Manatsathit; H Janaka de Silva; Rungsun Rerknimitr; Pises Pisespongsa; Muhamad Radzi Abu Hassan; Joseph Sung; Toshifumi Hibi; Christopher C M Boey; Neil Moran; Rupert W L Leong
Journal:  J Gastroenterol Hepatol       Date:  2016-01       Impact factor: 4.029

3.  Serological markers facilitate the diagnosis of Crohn's disease.

Authors:  Xin Gao; Yan Zhang
Journal:  Postgrad Med       Date:  2021-02-02       Impact factor: 3.840

4.  Differentiation of Crohn's disease from intestinal tuberculosis by clinical and CT enterographic models.

Authors:  Xue-Song Zhao; Zheng-Ting Wang; Zhi-Yuan Wu; Qi-Hua Yin; Jie Zhong; Fei Miao; Fu-Hua Yan
Journal:  Inflamm Bowel Dis       Date:  2014-05       Impact factor: 5.325

5.  Risk factors for diagnostic delay in Crohn's disease and their impact on long-term complications: how do they differ in a tuberculosis endemic region?

Authors:  R Banerjee; P Pal; B G Girish; D N Reddy
Journal:  Aliment Pharmacol Ther       Date:  2018-03-24       Impact factor: 8.171

6.  Explainable machine-learning predictions for the prevention of hypoxaemia during surgery.

Authors:  Scott M Lundberg; Bala Nair; Monica S Vavilala; Mayumi Horibe; Michael J Eisses; Trevor Adams; David E Liston; Daniel King-Wai Low; Shu-Fang Newman; Jerry Kim; Su-In Lee
Journal:  Nat Biomed Eng       Date:  2018-10-10       Impact factor: 25.671

7.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.

Authors:  Fernando Gomollón; Axel Dignass; Vito Annese; Herbert Tilg; Gert Van Assche; James O Lindsay; Laurent Peyrin-Biroulet; Garret J Cullen; Marco Daperno; Torsten Kucharzik; Florian Rieder; Sven Almer; Alessandro Armuzzi; Marcus Harbord; Jost Langhorst; Miquel Sans; Yehuda Chowers; Gionata Fiorino; Pascal Juillerat; Gerassimos J Mantzaris; Fernando Rizzello; Stephan Vavricka; Paolo Gionchetti
Journal:  J Crohns Colitis       Date:  2016-09-22       Impact factor: 9.071

8.  Analysis of Phenotypic Variables and Differentiation Between Untypical Crohn's Disease and Untypical Intestinal Tuberculosis.

Authors:  Yu Meng; Ying Li; Rong Hao; Xiaojun Li; Fanggen Lu
Journal:  Dig Dis Sci       Date:  2019-02-06       Impact factor: 3.487

9.  Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia.

Authors:  Julajak Limsrivilai; Choon Kin Lee; Piyapan Prueksapanich; Kamin Harinwan; Asawin Sudcharoen; Natcha Cheewasereechon; Satimai Aniwan; Pimsiri Sripongpan; Panu Wetwittayakhlang; Ananya Pongpaibul; Anapat Sanpavat; Nonthalee Pausawasdi; Phunchai Charatcharoenwitthaya; Peter D R Higgins; Siew Chien Ng
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

10.  Misdiagnosis and Mistherapy of Crohn's Disease as Intestinal Tuberculosis: Case Report and Literature Review.

Authors:  Jiang-Peng Wei; Xiao-Yan Wu; Sen-Yang Gao; Qiu-Yu Chen; Tong Liu; Gang Liu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.